Clinical Trial Update: Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the combination of etanercept and methotrexate for plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Etanercept (Enbrel) (Etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Psoriasis, Arthritis, Psoriatic | Phase 4 | Status: COMPLETED